TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Exagen Inc. Announces Select Preliminary 2025 Financial Results

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Na
Exagen Inc. Announces Select Preliminary 2025 Financial Results

Exagen Inc. (Nasdaq: XGN) announced preliminary 2025 financial results showing record full-year revenue of $66M-$67M, representing 19-20% year-over-year growth. The company achieved AVISE CTD test volume growth of 11% and trailing 12-month average selling price expansion of at least $30 compared to 2024. Year-end cash position strengthened to $32M, up $10M from 2024. CEO John Aballi highlighted strong execution across teams and recent platform enhancements despite ASP headwinds in the second half of the year.

Insights
JPMpL   neutral

Mentioned as launching tokenization initiatives without specific details about success or scale


XGN   positive

Company reported record full-year revenue with 19-20% YoY growth, achieved 11% test volume growth, demonstrated ASP expansion of at least $30, increased cash position by $10M to $32M, launched platform enhancements, and strengthened scientific and commercial teams. CEO expressed confidence in execution and future strategy despite some mid-year ASP headwinds.